Literature DB >> 9519179

Localised carcinoma of the prostate: a paradigm of uncertainty.

S S Sandhu1, A V Kaisary.   

Abstract

The incidence and prevalence of prostate cancer is increasing. A number of aetiological factors including age, race, family history and diet have been implicated. The majority of patients present with disease which is amenable only to palliation. Digital rectal examination, serum prostate-specific antigen and transrectal ultrasound can lead to a prostatic biopsy. Transrectal ultrasound, magnetic resonance imaging, bone scan and a chest X-ray are used for staging. The management of localised cancer is shrouded in uncertainty. Three options exist, watchful waiting, radiotherapy, and radical total prostatectomy. The published data are inadequate for a valid comparison of these, and none has been shown to offer an advantage. Surgery, and to a lesser degree radiotherapy, have a significant morbidity. It is hoped that through better understanding our management of this disease will improve.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9519179      PMCID: PMC2431575          DOI: 10.1136/pgmj.73.865.691

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  36 in total

1.  Total prostatectomy for clinically localized prostatic cancer: long-term results.

Authors:  R P Gibbons; R J Correa; G E Brannen; R M Weissman
Journal:  J Urol       Date:  1989-03       Impact factor: 7.450

2.  Prostatic disorders: MR imaging at 1.5 T.

Authors:  M E Phillips; H Y Kressel; C E Spritzer; P H Arger; A J Wein; D Marinelli; L Axel; W B Gefter; H M Pollack
Journal:  Radiology       Date:  1987-08       Impact factor: 11.105

Review 3.  Transrectal US of the prostate: is the technology leading the science?

Authors:  B L McClennan
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

4.  Technetium-99M polyphosphate bone scanning in carcinoma of the prostate.

Authors:  B C Lentle; D G McGowan; H Dierich
Journal:  Br J Urol       Date:  1974-10

5.  The echogenic focus in prostatic sonograms, with xeroradiographic and histopathologic correlation.

Authors:  W F Dähnert; U M Hamper; P C Walsh; J C Eggleston; R C Sanders
Journal:  Radiology       Date:  1986-04       Impact factor: 11.105

6.  Natural history of localised prostatic cancer. A population-based study in 223 untreated patients.

Authors:  J E Johansson; H O Adami; S O Andersson; R Bergström; U B Krusemo; W Kraaz
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

7.  Prostatic carcinoma: staging with MR imaging at 1.5 T.

Authors:  M Bezzi; H Y Kressel; K S Allen; M L Schiebler; H G Altman; A J Wein; H M Pollack
Journal:  Radiology       Date:  1988-11       Impact factor: 11.105

8.  The accuracy of CT in the staging of carcinoma of the prostate.

Authors:  J F Platt; R L Bree; R E Schwab
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

9.  Natural history of localised prostatic cancer managed by conservative therapy alone.

Authors:  N J George
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

10.  Is prostate cancer worth diagnosing?

Authors:  J Waxman; D Sheer
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

View more
  2 in total

1.  Treatment decisions for localized prostate cancer: asking men what's important.

Authors:  E S Holmboe; J Concato
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

2.  Analysis of outcome following robotic assisted radical prostatectomy for patients with high risk prostate cancer as per D'Amico classification.

Authors:  Narmada Prasad Gupta; Anandan Murugesan; Anand Kumar; Rajiv Yadav
Journal:  Indian J Urol       Date:  2016 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.